Biologic Therapies for Moderate to Severe Asthma in the Pediatric Population: A Practice Update

被引:1
|
作者
Tolomeo, Concettina [1 ]
机构
[1] Yale Univ, Sch Med, Sect Pediat Pulmonol Allergy Immunol & Sleep Med, New Haven, CT 06520 USA
来源
SAGE OPEN NURSING | 2023年 / 9卷
关键词
asthma; biologics; pediatrics; childhood;
D O I
10.1177/23779608231154041
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
IntroductionAsthma is a common childhood condition. Up until recent years, the mainstay of long-term control treatment has been inhaled corticosteroids. While inhaled corticosteroids are very effective for most children with asthma, with the introduction of biologic therapies, additional options now exist for children with uncontrolled moderate to severe asthma. PurposeThe purpose of this Practice Update is to provide nursing professionals with a summary of the biologic therapies currently available for the pediatric population and, to describe when they are indicated for inclusion in the plan of care for children with moderate to severe asthma. ConclusionBy properly diagnosing asthma, and, selecting and administering appropriate asthma therapies, nursing professionals can help children with moderate to severe asthma lead healthy and active lives.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GERMANY
    Betts, K.
    Yan, Y.
    Sundaram, M.
    Hengst, N.
    Wolff, M.
    Bensimon, A. G.
    VALUE IN HEALTH, 2012, 15 (07) : A570 - A570
  • [42] ECONOMIC EVALUATION MODEL OF BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PSORIATIC ARTHRITIS IN GERMANY
    Wang, X.
    Bansback, N.
    Anis, A.
    Joshi, A. D.
    Rao, S.
    Wolff, M.
    Cifaldi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A446 - A446
  • [43] Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States
    Anis, Aslam H.
    Bansback, Nick
    Sizto, Sonia
    Gupta, Shiraz R.
    Willian, Mary K.
    Feldman, Steve R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (02) : 65 - 74
  • [44] Biologic Therapies for Moderate-to-Severe Asthma and Its Comorbidities: What Can Medical Education Reveal About Barriers to Their Adoption?
    Drexel, C.
    Wilson, E.
    Guilbert, T. W.
    Peters, A.
    Denham, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [45] Update on the utilization of complementary therapies by adolescents with asthma in an urban population
    Soffer, Gary K.
    Feinberg, Termeh
    Kroll, Hillary
    Reznik, Marina
    JOURNAL OF ASTHMA, 2025,
  • [46] Biologic Targeted Therapies for the Phenotypes of Type-2 High Severe Asthma
    Yilmaz, Insu
    Turk, Murat
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (03): : 1091 - 1092
  • [47] Severe asthma at COVID-19 time: what is new on biologic therapies
    Patrucco, Filippo
    Villa, Elisa
    Foci, Valentina
    Benfante, Alida
    Bellocchia, Michela
    Solidoro, Paolo
    MINERVA MEDICA, 2021, 112 (01) : 114 - 117
  • [48] Racial and Ethnic Disparities in Biologic Prescriptions for Moderate-to-Severe Persistent Asthma
    Sylvestre, Sebastian
    Kaminsky, Lauren
    Al-Shaikhly, Taha
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB151 - AB151
  • [49] Early Outcomes and Comparisons of Biologic Therapy for Severe Asthma in a Pediatric Cohort
    Koka, N.
    Perry, T.
    Jefferson, A.
    Pertzborn, M.
    Ararat, E.
    Stewart, S.
    Cobb, K.
    Long, H.
    Pesek, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Mechanisms Mediating Pediatric Severe Asthma and Potential Novel Therapies
    Alonso, Aldara Martin
    Saglani, Sejal
    FRONTIERS IN PEDIATRICS, 2017, 5